Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Other financing activities: 2018-2024

Historic Other financing activities for Dianthus Therapeutics (DNTH) over the last 1 years, with Jun 2024 value amounting to $2.2 million.

  • Dianthus Therapeutics' Other financing activities was N/A to $2.2 million in Q2 2024 from the same period last year, while for Jun 2024 it was $15.3 million, marking a year-over-year change of. This contributed to the annual value of $14.7 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Dianthus Therapeutics reported Other financing activities of $2.2 million as of Q2 2024, which was down 81.94% from $12.4 million recorded in Q1 2024.
  • Over the past 5 years, Dianthus Therapeutics' Other financing activities peaked at $12.4 million during Q1 2024, and registered a low of $2.2 million during Q2 2024.
  • Moreover, its 1-year median value for Other financing activities was $7.3 million (2024), whereas its average is $7.3 million.